PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200 | -100.0% | 12 | -100.0% | 0.00% | -100.0% |
| Q2 2023 | $1,202,076 | -47.8% | 43,522 | -56.5% | 0.00% | -60.0% |
| Q1 2023 | $2,301,978 | +6.0% | 100,086 | -49.7% | 0.01% | +25.0% |
| Q4 2022 | $2,170,750 | +11.7% | 198,969 | -13.8% | 0.00% | 0.0% |
| Q3 2022 | $1,944,000 | -15.1% | 230,847 | -20.3% | 0.00% | -20.0% |
| Q2 2022 | $2,289,000 | -47.2% | 289,562 | +58.1% | 0.01% | -37.5% |
| Q1 2022 | $4,335,000 | -22.5% | 183,116 | +11.9% | 0.01% | -11.1% |
| Q4 2021 | $5,593,000 | +310.3% | 163,589 | +112.4% | 0.01% | +350.0% |
| Q3 2021 | $1,363,000 | -43.7% | 77,002 | +42.6% | 0.00% | -50.0% |
| Q2 2021 | $2,422,000 | +84.5% | 54,004 | +6.4% | 0.00% | +100.0% |
| Q1 2021 | $1,313,000 | +18.5% | 50,733 | -7.9% | 0.00% | 0.0% |
| Q4 2020 | $1,108,000 | -46.7% | 55,060 | -48.2% | 0.00% | -50.0% |
| Q3 2020 | $2,080,000 | -35.1% | 106,352 | -41.5% | 0.00% | -42.9% |
| Q2 2020 | $3,205,000 | +335.5% | 181,736 | +74.0% | 0.01% | +250.0% |
| Q1 2020 | $736,000 | +120.4% | 104,440 | +119.6% | 0.00% | +100.0% |
| Q4 2019 | $334,000 | -63.9% | 47,568 | -38.1% | 0.00% | -50.0% |
| Q3 2019 | $926,000 | +1418.0% | 76,835 | +1202.3% | 0.00% | – |
| Q3 2018 | $61,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |